Hu Liu
Memorial University of Newfoundland, Canada
Biography
Hu Liu, Ph.D., School of Pharmacy, Memorial University of Newfoundland, ST. John's, NL, CANADA Following his B.Sc. (Pharmacy) in 1982 from Beijing Medical College and M.Sc. (Pharmaceutical chemistry) degrees from Beijing Medical University (now Peking University) in Beijing, China, Dr. Liu obtained his Ph.D. degree in lipid and lipoprotein biochemistry from the University of Alberta in 1993 in Canada. He then did his post-doctoral training in pharmacology and medicinal chemistry at the University of Michigan, Ann Arbor MI, USA. In 1994, Dr. Liu joined School of Pharmacy, Memorial University, and he is a full professor. From 1999 to 2004, Dr. Liu was a recipient of the Career Award in Health Sciences sponsored by Medical Research Council of Canada (MRC) which was renamed as Canadian Institutes of Health Research (CIHR) and the Health Sciences Foundation of Canada's Research Based Pharmaceutical Companies (Rx&D-HRF). In 2000, he was awarded with the AstraZeneca New Investigator Research Award by the Association of Faculties of Pharmacy of Canada (AFPC). He served as an internal grants reviewer for the Pharmaceutical Sciences Committee of CIHR. In 2002, together with three colleagues Dr. Liu founded the former North Atlantic BioPharma Inc., a biotech company focused on developing marine based pharmaceuticals. Dr. Liu was the President and Chief Scientific Officer of the company. His research activities were funded by many agencies including MRC/CIHR, Banting Foundation, National Research Council of Canada (NRC), Atlantic Canada Opportunities Agency (ACOA) and International Science and Technology Partnership Canada (ISTPCanada). Dr. Liu's research interests include: development of drugs and drug delivery systems in the areas of cancer, cardiovascular disease and inflammation in addition to cold ocean derived pharmaceuticals
Abstract
Abstract : Potential pharmaceutical applications of Omega-3 oil derived from marine mammals